Liminal BioSciences Inc. (NASDAQ:LMNL) (“Liminal BioSciences” or the “Company”), announced that a consolidation of all of the issued and outstanding common shares of the Company (“Common Shares”) on the basis of a consolidation ratio of ten (10) pre-consolidation Common Shares for one (1) post-consolidation Common Share (the “Share Consolidation”), will become effective at the opening of trading on February 1, 2023 (the “Effective Date”). The Company’s current trading symbol will remain unchanged. The Consolidation was previously approved by the Company’s shareholders at the special meeting of the shareholders held on January 20, 2023.
Advertisers Are Secretly Fearing Twitter With Musk At The Helm – And He Needs Them
As Elon Musk closed the Twitter deal, it appeared that months of uncertainty and bickering may now be a thing of the past and the billionaire could proceed unhindered to accomplish his declared intent of making the platform o
